The density of CD45+ immune cells in the tumor stroma, excluding necrotic areas and peripheral stroma, was 2.0- and 3.4-fold higher in low and high dose DOX-treated turmors, respectively, compared to tumors in the saline control group (Figure 3d). This evidence concerns the gene PTPRC and neoplasm.